🔓 Unlock the full profile of Himanshu Shah (Cytecare Hospitals), including verified contact details, financial insights, and professional associations.
See Himanshu Shah Full ProfileBelow are the ✅ Verified Contact Details to help you connect directly:
Email: him*****@cyt******.com
Mobile: 91943*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Himanshu Shah is a notable figure in the healthcare sector, serving as Co-founder and Director at Cytecare Cancer Hospitals since March 2014, contributing to the establishment of a specialized cancer care facility aimed at improving patient outcomes.
- In addition to Cytecare, Himanshu co-founded Cytespace Research Private Limited in May 2011, focusing on advancing clinical research and innovation in the medical field.
- Himanshu has extensive experience in healthcare management, having worked as Co-founder and Director in various capacities, including self-employment starting from January 2011.
- Previously, from November 2009 to March 2011, held the position of Executive Director - Corporate Development at Quintiles - India, showcasing leadership in corporate strategy and business development.
- Earlier experience includes serving as Executive Director - Project Finance at Quintiles India from January 2005 to October 2009, demonstrating financial acumen in the management of project resources.
- At Cytecare Hospitals, significant milestones include the introduction of patient-centric care models, integrating advanced medical technologies and treatment protocols to enhance service delivery.
- Himanshu has faced challenges within the evolving landscape of healthcare, adapting to regulations and market dynamics while focusing on quality patient care and operational efficiency.
- With a commitment to research and development, contributions have also been made in promoting collaborative studies and partnerships within the healthcare community to drive innovation.
- Under the leadership of Himanshu, Cytecare Hospitals aims to set benchmarks in cancer treatment and establish standards that could serve as a model for similar institutions nationally and beyond.